Cooperative Agreement HITEP210051
Award Date
9/30/21
Completion Date
10/12/22
Dollars Obligated
$175K
Federal Grant Program
93.078
Assistance Type
Cooperative Agreement
Place of Performance
Rhode Island, USA
Similar Awards
This federal Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) through the Emerging Infections Programs (CFDA 93.317), will establish a nationwide cohort of blood donors to estimate the burden of respiratory viruses and the associated immunologic response. The total funding amount is $4,500,000 with a 5-year performance period from September 2024 to August 2029. The primary awardee, Vitalant, will lead the development and maintenance of the...
This $39,597,587 Cooperative Agreement award from the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response supports the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The Florida Department of Health is the primary recipient, responsible for enhancing healthcare systems' readiness for responding to public health emergencies, terrorism, and large-scale medical crises. Key objectives include strengthening hospital and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $286,510 Cooperative Agreement under the Blood Disorder Program: Prevention, Surveillance, and Research (CFDA 93.080) to the Center for Public Health Innovation, a woman-owned non-profit organization, for the Sickle Cell Data Collection Program - 2023. This 5-year project, beginning on September 30, 2023, aims to work with state health agencies and other partners to plan, develop, implement, coordinate, and evaluate programs and...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $35,976,134 cooperative agreement to the Pennsylvania Department of Health (PADOH) under the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The award period is from July 1, 2024 to June 30, 2029. The cooperative agreement funds PADOH's efforts to enhance healthcare system readiness and response capabilities for public health emergencies, terrorism, and mass...
This Cooperative Agreement award, funded by the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, supports the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The award, totaling $16,307,182, aims to enhance healthcare systems' readiness for responding to public health emergencies, terrorism, and large-scale medical crises. Key objectives include strengthening hospital and healthcare coalition capabilities,...
This $15,072,720.00 Cooperative Agreement award from the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (CFDA 93.889 - National Bioterrorism Hospital Preparedness Program) aims to enhance healthcare systems' readiness for responding to public health emergencies, terrorism, and large-scale medical crises. The program focuses on developing infrastructure, training protocols, and response mechanisms to improve healthcare delivery...
This Cooperative Agreement award, totaling $5,451,237.00, was issued by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response under the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The grant aims to enhance healthcare systems' readiness and response capabilities for public health emergencies, terrorism, and large-scale medical crises. Key activities under this Cooperative Agreement include strengthening hospital...
This $61,822,336.47 Cooperative Agreement was awarded on September 12, 2024 by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Biomedical Advanced Research and Development Authority (BARDA) Biodefense Medical Countermeasure Development program (CFDA 93.360). The primary awardee, Endo USA, Inc., will use the funding to advance research and development of medical countermeasures, including vaccines, therapeutics,...
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $26,838,866 Cooperative Agreement to the State of North Carolina Department of Health & Human Services to fund the North Carolina's Healthcare Preparedness Program. This 5-year award, running from July 1, 2024 to June 30, 2029, is provided under the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The program aims to enhance healthcare systems'...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded the Virginia State Board of Health (VA SBOH) a $27,456,197 Cooperative Agreement under the National Bioterrorism Hospital Preparedness Program (CFDA 93.889). The award spans a 5-year period from July 1, 2024 to June 30, 2029 and aims to enhance healthcare systems' readiness for responding to public health emergencies, terrorism, and large-scale medical crises. Key objectives...